Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention-Reference-Cited by-同舟云学术

Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention

Published:2015-06-26 Issue:6 Volume:10 Page:e0131394
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nishikawa Takuro,Miyahara Emiko,Kurauchi Koichiro,Watanabe Erika,Ikawa Kazuro,Asaba Kousuke,Tanabe Takayuki,Okamoto Yasuhiro,Kawano Yoshifumi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. The use of cyclophosphamide for clinical marrow transplantation;GW Santos;Transplant Proc,1972

2. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen—a report from the acute leukemia working party of the European group for blood and marrow transplantation;A Nagler;J Clin Oncol,2013

3. Specific destruction of host-reactive mature T cells of donor origin prevents graft versus-host disease in cyclophosphamide-induced tolerant mice;M Eto;J Immunol,1991

4. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide;PV O’Donnell;Biol Blood Marrow Transplant,2002

5. Cyclophosphamide and cancer: golden anniversary;A Emadi;Nat Rev Clin Oncol,2009

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC;Bone Marrow Transplantation;2024-09-14

2. Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults;JACC: CardioOncology;2024-08

3. Cardiac Events Occurring after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Study Conducted on Behalf of the GETH-TC;2024-07-26

4. Effects of High-Dose Cyclophosphamide on Ultrastructural Changes and Gene Expression Profiles in the Cardiomyocytes of C57BL/6J Mice;Diseases;2024-04-27

5. Association between B-type natriuretic peptide levels after the first dose of cyclophosphamide and early cardiac events and transplantation outcomes;2024-04-10